Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
| Revision | Operations | |
|---|---|---|
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | current revision | |
| 02-7-25 by ripal121 ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | ||
| 02-7-25 by conan.macdougal... [email protected] replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module. | ||
| 10-26-23 by ripal121 | ||
| 10-26-23 by ripal121 | ||
| 10-26-23 by ripal121 | ||
| 10-26-23 by ripal121 | ||
| 10-26-23 by ripal121 | ||
| 10-26-23 by kaipe | ||
| 10-26-23 by ripal121 | ||
| 10-26-23 by ripal121 | ||
| 10-19-23 by tasissah Adult ID/ASP may recommend 9 g IV q 8h (with extended infusion over 4 hours) in certain cases | ||
| 10-19-23 by tasissah | ||
| 10-19-23 by tasissah | ||
| 09-25-23 by ripal121 | ||
| 09-25-23 by ripal121 | ||
| 09-25-23 by ripal121 | ||
| 09-1-23 by ripal121 | ||
| 09-1-23 by ripal121 | ||
| 10-14-20 by [email protected] | ||
| 10-5-20 by [email protected] | ||
| 10-5-20 by [email protected] | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 08-12-20 by conan.macdougal... | ||
| 07-10-20 by [email protected] | ||
| 07-7-20 by [email protected] | ||
| 07-7-20 by [email protected] | ||
| 07-7-20 by [email protected] | ||
| 07-7-20 by [email protected] | ||
| 07-7-20 by [email protected] | ||
| 07-7-20 by [email protected] | ||
| 04-17-20 by ucsf_admin | ||
| 04-17-20 by ucsf_admin | ||
Dosing: Adult Antimicrobial Dosing, Non-dialysis
| Indication | CrCl > 30 mL/min |
15 – 30 mL/min |
< 15 mL/min |
|---|---|---|---|
| All indications | 3 g IV q6h | 3 g IV q12h | 3 g IV q24h |
|
Carbapenem-resistant Acinetobacter baumannii |
3 g IV q4h | 3 g IV q8h |
3 g IV q12h
|
Extended Infusion Dosing (if recommended by ID or ID pharmacy)
| Indication | CrCl > 60 mL/min |
30-59 mL/min |
<30mL/min |
|---|---|---|---|
|
Carbapenem-resistant Acinetobacter baumannii |
9 gram IV q 8h (over 4 hours) |
6 grams IV q 8h (over 4 hours) |
Short infusion (follow the dosing recs of 3 g IV q 4h schematic) |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
|
Indication |
Intermittent Hemodialysis |
Continuous Hemodialysis |
|---|---|---|
| All Indications | 3g IV q12h | 3g IV q6h |
|
Carbapenem-resistant Acinetobacter baumannii |
3g IV q12h | 3g IV 4h |